Blood biomarker may detect lung cancer, study presented at CHEST 2014

Key points
- A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer.
- Researchers at Cleveland Clinic studied the blood serum of 284 subjects, 48% of whom were female with a mean age of 68 years.
- "Our study results showed that patients with lung cancer have altered metabolic processes," said Peter J.
- CHEST 2014 is the 80th annual meeting of the American College of Chest Physicians (CHEST), held October 25-30, 2014, in Austin, Texas.
A new study shows that patients with stage I to stage III non-small cell lung cancer have different metabolite profiles in their blood than those of patients who are at risk but do not have lung cancer. The study abstract was released today in an online supplement of the journal CHEST and will be presented at CHEST 2014, the annual meeting of the American College of Chest Physicians in Austin, Texas, on October 29.
Researchers at Cleveland Clinic studied the blood serum of 284 subjects, 48% of whom were female with a mean age of 68 years. The subjects were diagnosed with adenocarcinoma or squamous lung cancer: 44% of those at stage I, 17% at stage II, and 39% at stage III. A control group of 194 patients - who matched the cancer patients in age, gender, smoking history, COPD, diabetes, and blood lipids were at risk for lung cancer but did not have the disease. There were 534 metabolites identified, with the concentration of 149 metabolites differing significantly between the cancer and control groups.
"Our study results showed that patients with lung cancer have altered metabolic processes," said Peter J. Mazzone, MD, FCCP, Director of the Lung Cancer Program for the Respiratory Institute at Cleveland Clinic. "This information could lead to the development of a diagnostic biomarker for early detection of lung cancer."
CHEST 2014 is the 80th annual meeting of the American College of Chest Physicians (CHEST), held October 25-30, 2014, in Austin, Texas. The American College of Chest Physicians, publisher of the journal CHEST, is the global leader in advancing best patient outcomes through innovative chest medicine education, clinical research, and team-based care.
Its mission is to champion the prevention, diagnosis, and treatment of chest diseases through education, communication, and research. It serves as an essential connection to clinical knowledge and resources for its 18,700 members from around the world who provide patient care in pulmonary, critical care, and sleep medicine. For information about the American College of Chest Physicians, visit chestnet.org, or follow the CHEST meeting hashtag, #CHEST2014, on social media.
###
Kristi Bruno
kbruno@chestnet.org
773-750-9962
American College of Chest Physicians
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsAn "HIV-test" Equivalent for the Early Detection of Lung Cancer
A team of researchers led by Fred Hutchinson Cancer Research Center reports online today in the Journal of Clinical Oncology the validation of a potential “HIV-test” equivalent for the early detection of lung cancer.…
17 September 2008
NewsSymptom screening plus a simple blood test improves early detection of ovarian cancer
Women's reports of persistent, recent-onset symptoms linked to ovarian cancer – abdominal or pelvic pain, difficulty eating or feeling full quickly and abdominal bloating – when combined with the CA125 blood test may…
24 June 2008
NewsBlood Test for Lung Cancer May be Possible
A simple blood test may be able to detect lung cancer in its earliest stages with unprecedented accuracy, according to new research to be presented at American Thoracic Society’s 2008 International Conference in Toronto…




